This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Shortage Avoided

VEPESID

BRISTOL-MYERS SQUIBB CANADA

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of VEPESID in Canada?

Yes. VEPESID 50MG has an active shortage reported to Health Canada (last updated October 27, 2026).

Why is VEPESID not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will VEPESID be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist

StatusShortage Avoided

Same-ingredient products on fileNone found

Affected strength50MG

Report last updated2018-12-20

Checked by MedShort2026-11-12

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

00616192

Strength

50MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

ETOPOSIDE

Tier

Unrated

Last Updated

2018-12-20

Reason for Shortage

Delay in shipping of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

VEPESID has 2 shortage/discontinuation reports on file — this is one of them.

2026-10-27

Active Shortage

Disruption of the manufacture of the drug.

Other Products from BRISTOL-MYERS SQUIBB CANADA

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ABRAXANE FOR INJECTABLE SUSPENSION

100MG · DIN 02281066

BARACLUDE

0.5MG · DIN 02282224

BREYANZI

120000000CELLS · DIN 02527138

CAMZYOS

15MG · DIN 02532573

CAMZYOS

5MG · DIN 02532557

CAMZYOS

2.5MG · DIN 02532549